#United States #New York #Blue Owl Capital #Spire Healthcare #Moor Park Capital

Blue Owl Capital Completes Acquisition of Spire Healthcare Portfolio

In a significant move within the healthcare investment sector, Blue Owl Capital Inc. (NYSE: OWL) has announced the successful acquisition of a portfolio comprising 12 acute-care hospitals from Spire Healthcare Group plc, the largest private hospital operator in the UK. This strategic acquisition, completed in conjunction with Moor Park Capital Partners, represents a vital step in Blue Owl's broader investment strategy, particularly focusing on European real estate in the healthcare sector.

According to Marc Zahr, Co-President and Global Head of Real Assets at Blue Owl, the acquisition is more than just a portfolio expansion; it is a strategic investment. Zahr emphasized that the move encompasses well-structured long-term leases with a market-leading tenant, signaling a robust investment in high-quality private healthcare facilities in the UK. This initiative dramatically accelerates Blue Owl's strategy of increasing its presence in essential real estate sectors, particularly in a market facing strong demand for healthcare services.

“The Spire portfolio not only enriches our offerings but is a crucial piece of our continued expansion in European net lease strategies,” Zahr stated. He highlighted the strong fundamentals underlying the demand for healthcare real estate, reinforcing the firm’s commitment to channeling resources where the need is most pressing.

This acquisition aligns with Blue Owl's approach to leveraging its extensive experience across the healthcare landscape. The strategic significance lies in the favorable supply-demand dynamics characterizing the European healthcare real estate asset class, which offers the potential for compelling value generation for investors and the communities served by these healthcare facilities.

The completion of this acquisition also marks a pivotal milestone for Blue Owl's Real Assets platform, enhancing the firm's capacity to navigate and capitalize on the expanding healthcare real estate markets. Blue Owl aims to harness its institutional scale and investment expertise to forge long-term growth paths. The firm has cultivated extensive relationships within the real estate market, which it plans to leverage for ongoing growth and value creation from the Spire portfolio.

Financing for this significant transaction was facilitated through a newly secured term loan, with notable participation from Standard Chartered Bank, Natixis, and Crédit Agricole CIB, who acted as joint mandated lead arrangers and lenders for the deal.

Industry experts agree that the choice to invest in healthcare real estate, particularly underlined by such significant facilities as those within the Spire network, indicates a vibrant pathway for Blue Owl and Moor Park. As the companies look ahead, they plan to continue pursuing opportunities in the European healthcare sector that present strong risk-adjusted returns.

Rothschild & Co served as the exclusive financial advisor for Blue Owl on this transaction, while Kirkland & Ellis and Hogan Lovells acted as legal counsel. Deloitte provided tax and financial due diligence expertise, ensuring a thorough investigation into the investment's viability.

About Blue Owl Capital

Blue Owl is a major asset manager, specializing in alternative investments and innovative financing solutions. As of March 31, 2026, they boast an impressive $315 billion in assets under management. The firm operates across three multifaceted investment strategies: Credit, Real Assets, and GP Strategic Capital. They are committed to creating lasting value, focusing on long-term industry growth, and delivering strong risk-adjusted returns for investors.

For more information on Blue Owl Capital, please visit www.blueowl.com.

About Moor Park Capital Partners

Founded over two decades ago, Moor Park Capital Partners specializes in international real estate private equity investment. The firm’s focus spans across various operational real estate sectors, including healthcare, logistics, and hospitality, establishing a reputation for its ability to navigate complex transactions successfully, consistently delivering strong investment performance.

For further inquiries regarding this acquisition, please reach out to Ann Dai, Head of Investor Relations at Blue Owl Capital.